Literature DB >> 28295036

A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population.

Stojan Perić1, Jelena Nikodinović Glumac2, Ana Töpf3, Dušanka Savić-Pavićević4, Lauren Phillips3, Katherine Johnson3, Marcus Cassop-Thompson3, Liwen Xu5,6, Marta Bertoli3, Monkol Lek5,6, Daniel MacArthur5,6, Miloš Brkušanin4, Sanja Milenković7, Vedrana Milić Rašić2, Bojan Banko8, Ružica Maksimović8, Hanns Lochmüller3, Vidosava Rakočević Stojanović1, Volker Straub3.   

Abstract

Variants in the TTN gene have been associated with distal myopathies and other distinctive phenotypes involving skeletal and cardiac muscle. Through whole-exome sequencing we identified a novel stop-gain variant (c.107635C>T, p.(Gln35879Ter)) in the TTN gene, coding a part of the M-line of titin, in 14 patients with autosomal recessive distal myopathy and Serbian ancestry. All patients share a common 1 Mb core haplotype associated with c.107635C>T, suggesting a founder variant. In compound heterozygotes, nine other TTN variants were identified: four stop-gain, three frameshift, one missense and one splice donor variant. Patients homozygous for the common variant did not show significant clinical differences to the compound heterozygous patients. The clinical presentation of all patients was an adult onset distal myopathy with predominant lower limb involvement. In addition, most patients had normal to mildly elevated serum creatine kinase levels, myopathic electromyograms, normal cardiologic and respiratory tests and muscle pathology consistent with a dystrophic process. In this study, we describe a distinct phenotype for patients with distal myopathy associated with novel recessive TTN variants including a Serbian founder variant. Our results expand the phenotypic and genetic spectrum of titinopathies and will facilitate the diagnosis of this condition in patients of Serbian origin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28295036      PMCID: PMC5437897          DOI: 10.1038/ejhg.2017.16

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  20 in total

1.  Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1-2 October 2009, Paris, France.

Authors:  Kieren G Hollingsworth; Paulo L de Sousa; Volker Straub; Pierre G Carlier
Journal:  Neuromuscul Disord       Date:  2012-10-01       Impact factor: 4.296

Review 2.  Molecular biology of distal muscular dystrophies--sarcomeric proteins on top.

Authors:  Bjarne Udd
Journal:  Biochim Biophys Acta       Date:  2006-08-18

3.  Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Authors:  K E Personius; S Pandya; W M King; R Tawil; M P McDermott
Journal:  Phys Ther       Date:  1994-03

4.  Atypical phenotypes in titinopathies explained by second titin mutations.

Authors:  Anni Evilä; Anna Vihola; Jaakko Sarparanta; Olayinka Raheem; Johanna Palmio; Satu Sandell; Bruno Eymard; Isabel Illa; Ricard Rojas-Garcia; Karolina Hankiewicz; Luis Negrão; Tuija Löppönen; Pekka Nokelainen; Mikko Kärppä; Sini Penttilä; Mark Screen; Tiina Suominen; Isabelle Richard; Peter Hackman; Bjarne Udd
Journal:  Ann Neurol       Date:  2014-02-24       Impact factor: 10.422

5.  Limb-girdle type muscular dystrophy in a large family with distal myopathy: homozygous manifestation of a dominant gene?

Authors:  B Udd
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

6.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.

Authors:  Peter Hackman; Anna Vihola; Henna Haravuori; Sylvie Marchand; Jaakko Sarparanta; Jerome De Seze; Siegfried Labeit; Christian Witt; Leena Peltonen; Isabelle Richard; Bjarne Udd
Journal:  Am J Hum Genet       Date:  2002-07-26       Impact factor: 11.025

7.  The first Italian family with tibial muscular dystrophy caused by a novel titin mutation.

Authors:  Marzia Pollazzon; Tiina Suominen; Sini Penttilä; Alessandro Malandrini; Maria Alessandra Carluccio; Mauro Mondelli; Annabella Marozza; Antonio Federico; Alessandra Renieri; Peter Hackman; Maria Teresa Dotti; Bjarne Udd
Journal:  J Neurol       Date:  2009-11-13       Impact factor: 4.849

8.  Myopathy with respiratory failure and typical myofibrillar lesions.

Authors:  L Edström; L E Thornell; J Albo; S Landin; M Samuelsson
Journal:  J Neurol Sci       Date:  1990-05       Impact factor: 3.181

9.  Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients.

Authors:  B Udd; J Partanen; P Halonen; B Falck; L Hakamies; H Heikkilä; S Ingo; H Kalimo; H Kääriäinen; V Laulumaa
Journal:  Arch Neurol       Date:  1993-06

10.  The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data.

Authors:  Sebastian Köhler; Sandra C Doelken; Christopher J Mungall; Sebastian Bauer; Helen V Firth; Isabelle Bailleul-Forestier; Graeme C M Black; Danielle L Brown; Michael Brudno; Jennifer Campbell; David R FitzPatrick; Janan T Eppig; Andrew P Jackson; Kathleen Freson; Marta Girdea; Ingo Helbig; Jane A Hurst; Johanna Jähn; Laird G Jackson; Anne M Kelly; David H Ledbetter; Sahar Mansour; Christa L Martin; Celia Moss; Andrew Mumford; Willem H Ouwehand; Soo-Mi Park; Erin Rooney Riggs; Richard H Scott; Sanjay Sisodiya; Steven Van Vooren; Ronald J Wapner; Andrew O M Wilkie; Caroline F Wright; Anneke T Vulto-van Silfhout; Nicole de Leeuw; Bert B A de Vries; Nicole L Washingthon; Cynthia L Smith; Monte Westerfield; Paul Schofield; Barbara J Ruef; Georgios V Gkoutos; Melissa Haendel; Damian Smedley; Suzanna E Lewis; Peter N Robinson
Journal:  Nucleic Acids Res       Date:  2013-11-11       Impact factor: 16.971

View more
  9 in total

1.  Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.

Authors:  Simon Edvardson; Claudia M Nicolae; Pankaj B Agrawal; Cyril Mignot; Katelyn Payne; Asuri Narayan Prasad; Chitra Prasad; Laurie Sadler; Caroline Nava; Thomas E Mullen; Amber Begtrup; Berivan Baskin; Zöe Powis; Avraham Shaag; Boris Keren; George-Lucian Moldovan; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2017-08-03       Impact factor: 11.025

2.  Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.

Authors:  Marco Savarese; Lorenzo Maggi; Anna Vihola; Per Harald Jonson; Giorgio Tasca; Lucia Ruggiero; Luca Bello; Francesca Magri; Teresa Giugliano; Annalaura Torella; Anni Evilä; Giuseppina Di Fruscio; Olivier Vanakker; Sara Gibertini; Liliana Vercelli; Alessandra Ruggieri; Carlo Antozzi; Helena Luque; Sandra Janssens; Maria Barbara Pasanisi; Chiara Fiorillo; Monika Raimondi; Manuela Ergoli; Luisa Politano; Claudio Bruno; Anna Rubegni; Marika Pane; Filippo M Santorelli; Carlo Minetti; Corrado Angelini; Jan De Bleecker; Maurizio Moggio; Tiziana Mongini; Giacomo Pietro Comi; Lucio Santoro; Eugenio Mercuri; Elena Pegoraro; Marina Mora; Peter Hackman; Bjarne Udd; Vincenzo Nigro
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

3.  De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.

Authors:  Dongxue Mao; Chloe M Reuter; Maura R Z Ruzhnikov; Anita E Beck; Emily G Farrow; Lisa T Emrick; Jill A Rosenfeld; Katherine M Mackenzie; Laurie Robak; Matthew T Wheeler; Lindsay C Burrage; Mahim Jain; Pengfei Liu; Daniel Calame; Sébastien Küry; Martin Sillesen; Klaus Schmitz-Abe; Davide Tonduti; Luigina Spaccini; Maria Iascone; Casie A Genetti; Mary K Koenig; Madeline Graf; Alyssa Tran; Mercedes Alejandro; Brendan H Lee; Isabelle Thiffault; Pankaj B Agrawal; Jonathan A Bernstein; Hugo J Bellen; Hsiao-Tuan Chao
Journal:  Am J Hum Genet       Date:  2020-03-19       Impact factor: 11.025

4.  A novel compound heterozygous mutation in the POMK gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair.

Authors:  Sonja Strang-Karlsson; Katherine Johnson; Ana Töpf; Liwen Xu; Monkol Lek; Daniel G MacArthur; Olivera Casar-Borota; Maria Williams; Volker Straub; Carina Wallgren-Pettersson
Journal:  Neuromuscul Disord       Date:  2018-05-16       Impact factor: 3.538

5.  Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness.

Authors:  Katherine Johnson; Marta Bertoli; Lauren Phillips; Ana Töpf; Peter Van den Bergh; John Vissing; Nanna Witting; Shahriar Nafissi; Shirin Jamal-Omidi; Anna Łusakowska; Anna Kostera-Pruszczyk; Anna Potulska-Chromik; Nicolas Deconinck; Carina Wallgren-Pettersson; Sonja Strang-Karlsson; Jaume Colomer; Kristl G Claeys; Willem De Ridder; Jonathan Baets; Maja von der Hagen; Roberto Fernández-Torrón; Miren Zulaica Ijurco; Juan Bautista Espinal Valencia; Andreas Hahn; Hacer Durmus; Tracey Willis; Liwen Xu; Elise Valkanas; Thomas E Mullen; Monkol Lek; Daniel G MacArthur; Volker Straub
Journal:  Skelet Muscle       Date:  2018-07-30       Impact factor: 4.912

6.  Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination.

Authors:  Alexander Mensch; Torsten Kraya; Felicitas Koester; Tobias Müller; Dietrich Stoevesandt; Stephan Zierz
Journal:  J Neurol       Date:  2020-05-02       Impact factor: 4.849

7.  Muscular dystrophy with arrhythmia caused by loss-of-function mutations in BVES.

Authors:  Willem De Ridder; Isabelle Nelson; Bob Asselbergh; Boel De Paepe; Maud Beuvin; Rabah Ben Yaou; Cécile Masson; Anne Boland; Jean-François Deleuze; Thierry Maisonobe; Bruno Eymard; Sofie Symoens; Roland Schindler; Thomas Brand; Katherine Johnson; Ana Töpf; Volker Straub; Peter De Jonghe; Jan L De Bleecker; Gisèle Bonne; Jonathan Baets
Journal:  Neurol Genet       Date:  2019-04-01

8.  Congenital Titinopathy: Comprehensive characterization and pathogenic insights.

Authors:  Emily C Oates; Kristi J Jones; Sandra Donkervoort; Amanda Charlton; Susan Brammah; John E Smith; James S Ware; Kyle S Yau; Lindsay C Swanson; Nicola Whiffin; Anthony J Peduto; Adam Bournazos; Leigh B Waddell; Michelle A Farrar; Hugo A Sampaio; Hooi Ling Teoh; Phillipa J Lamont; David Mowat; Robin B Fitzsimons; Alastair J Corbett; Monique M Ryan; Gina L O'Grady; Sarah A Sandaradura; Roula Ghaoui; Himanshu Joshi; Jamie L Marshall; Melinda A Nolan; Simranpreet Kaur; Jaya Punetha; Ana Töpf; Elizabeth Harris; Madhura Bakshi; Casie A Genetti; Minttu Marttila; Ulla Werlauff; Nathalie Streichenberger; Alan Pestronk; Ingrid Mazanti; Jason R Pinner; Carole Vuillerot; Carla Grosmann; Ana Camacho; Payam Mohassel; Meganne E Leach; A Reghan Foley; Diana Bharucha-Goebel; James Collins; Anne M Connolly; Heather R Gilbreath; Susan T Iannaccone; Diana Castro; Beryl B Cummings; Richard I Webster; Leïla Lazaro; John Vissing; Sandra Coppens; Nicolas Deconinck; Ho-Ming Luk; Neil H Thomas; Nicola C Foulds; Marjorie A Illingworth; Sian Ellard; Catriona A McLean; Rahul Phadke; Gianina Ravenscroft; Nanna Witting; Peter Hackman; Isabelle Richard; Sandra T Cooper; Erik-Jan Kamsteeg; Eric P Hoffman; Kate Bushby; Volker Straub; Bjarne Udd; Ana Ferreiro; Kathryn N North; Nigel F Clarke; Monkol Lek; Alan H Beggs; Carsten G Bönnemann; Daniel G MacArthur; Henk Granzier; Mark R Davis; Nigel G Laing
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

9.  The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark.

Authors:  Eva Leinøe; Nanna Brøns; Andreas Ørslev Rasmussen; Migle Gabrielaite; Carlo Zaninetti; Raghavendra Palankar; Eva Zetterberg; Steen Rosthøj; Sisse Rye Ostrowski; Maria Rossing
Journal:  J Thromb Haemost       Date:  2021-08-11       Impact factor: 16.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.